Squarepoint’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $294K | Buy |
+1,138
| New | +$303K | ﹤0.01% | 3731 |
|
|
2025
Q4 | – | Hold |
0
| – | – | – | 4654 |
|
|
2025
Q2 | – | Sell |
-81,999
| Closed | -$14.8M | – | 4818 |
|
|
2025
Q1 | $14.8M | Buy |
81,999
+72,440
| +758% | +$12.2M | 0.04% | 833 |
|
|
2024
Q4 | $1.5M | Sell |
9,559
-6,147
| -39% | -$1.09M | ﹤0.01% | 2681 |
|
|
2024
Q3 | $2.86M | Buy |
15,706
+13,298
| +552% | +$2.56M | 0.01% | 1808 |
|
|
2024
Q2 | $442K | Buy |
+2,408
| New | +$404K | ﹤0.01% | 3169 |
|
|
2024
Q1 | – | Sell |
-3,709
| Closed | -$460K | – | 4365 |
|
|
2023
Q4 | $460K | Buy |
+3,709
| New | +$411K | ﹤0.01% | 3069 |
|
|
2022
Q4 | – | Sell |
-8,320
| Closed | -$580K | – | 3441 |
|
|
2022
Q3 | $580K | Buy |
+8,320
| New | +$601K | 0.01% | 2132 |
|
|
2022
Q1 | – | Sell |
-21,794
| Closed | -$1.52M | – | 3225 |
|
|
2021
Q4 | $1.52M | Buy |
21,794
+8,909
| +69% | +$519K | 0.01% | 1421 |
|
|
2021
Q3 | $673K | Buy |
12,885
+8,384
| +186% | +$496K | ﹤0.01% | 1800 |
|
|
2021
Q2 | $306K | Buy |
+4,501
| New | +$314K | ﹤0.01% | 2511 |
|
|
2020
Q3 | – | Sell |
-5,758
| Closed | -$238K | – | 2682 |
|
|
2020
Q2 | $238K | Buy |
+5,758
| New | +$277K | ﹤0.01% | 1731 |
|
|
2020
Q1 | – | Sell |
-11,762
| Closed | -$651K | – | 2212 |
|
|
2019
Q4 | $651K | Sell |
11,762
-20,147
| -63% | -$988K | ﹤0.01% | 1605 |
|
|
2019
Q3 | $1.11M | Sell |
31,909
-7,519
| -19% | -$336K | 0.01% | 1162 |
|
|
2019
Q2 | $1.59M | Buy |
39,428
+32,777
| +493% | +$1.07M | 0.02% | 979 |
|
|
2019
Q1 | $219K | Buy |
+6,651
| New | +$157K | ﹤0.01% | 1912 |
|
|
2018
Q1 | – | Sell |
-10,800
| Closed | -$114K | – | 1931 |
|
|
2017
Q4 | $114K | Buy |
+10,800
| New | +$108K | ﹤0.01% | 1931 |
|
Other funds holding KRYS
ACA
VPM
VCM
SCM
RG
